Arkolith/Insider Trading/CBIO/Form 4

Harwin Peter Evan

Director, 10% OwnerCRESCENT BIOPHARMA, INC. (CBIO) · full profile →Form 4 · filed Dec 8, 2025
Net Buying
Open-Market Buys
$18.2M
Open-Market Sells
$0
Net Open-Market Flow
$18.2M
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2025Buy(P)1.4M$13.41$18.2M2.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 4, 2025Buy(P)131K$13.41$1.8M1.8M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-119320) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML